Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy

BACKGROUND: Cancer patients treated with neurotoxic chemotherapy are at risk of developing neurological symptoms that can impact functional capacity and quality of life. However, there are no standardised pathways to assess and manage chemotherapy-induced peripheral neurotoxicity (CIPN). This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizrahi, David, Goldstein, David, Kiernan, Matthew C., Robinson, Louisa, Pitiyarachchi, Omali, McCullough, Susan, Mendoza-Jones, Phil, Grimison, Peter, Boyle, Frances, Park, Susanna B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135801/
https://www.ncbi.nlm.nih.gov/pubmed/35394563
http://dx.doi.org/10.1007/s00520-022-07024-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135801/
https://www.ncbi.nlm.nih.gov/pubmed/35394563
http://dx.doi.org/10.1007/s00520-022-07024-3

Ejemplares similares